Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

Breast cancer is one of the major causes of cancer-related morbidity and mortality in women worldwide. During the past three decades, several improvements in the adjuvant treatment of hormone receptor-positive/HER2−negative breast cancer have been achieved with the introduction of optimized adjuvant...

Full description

Bibliographic Details
Main Authors: Mattia Garutti, Gaia Griguolo, Andrea Botticelli, Giulia Buzzatti, Carmine De Angelis, Lorenzo Gerratana, Chiara Molinelli, Vincenzo Adamo, Giampaolo Bianchini, Laura Biganzoli, Giuseppe Curigliano, Michelino De Laurentiis, Alessandra Fabi, Antonio Frassoldati, Alessandra Gennari, Caterina Marchiò, Francesco Perrone, Giuseppe Viale, Claudio Zamagni, Alberto Zambelli, Lucia Del Mastro, Sabino De Placido, Valentina Guarneri, Paolo Marchetti, Fabio Puglisi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
breast cancer
hormone receptors
adjuvant
endocrine therapy
chemotherapy
risk of relapse
Online Access:https://www.mdpi.com/2072-6694/14/8/1898

Similar Items

Similar Items